Global Cell Harvesting Market to Exceed USD 11.68 Billion by 2031, Fueled by Growth in Cell Therapy and Biomanufacturing
[Boston, 4 July 2025] – Clearview Market Insights (CVMI) predicts that the global cell harvesting market will increase from USD 5.21 billion in 2024 to USD 11.68 billion by 2031, with a compound annual growth rate (CAGR) of 12.1%. The rising demand for advanced cell harvesting technologies is driven by the growth in regenerative medicine, CAR-T cell therapy, and biomanufacturing.
Cell harvesting is a crucial step in translating research into clinical applications. As demand for cell therapies and biologics increases, the importance of scalable, automated, and contamination-free harvesting solutions has never been more evident," said Dr. Rina Gupta, senior bioprocessing analyst at CVMI.
Request Sample @ https://clearviewmarketinsights.com/report-details/global-cell-harvesting-market/
Key Market Highlights
- 2024 Market Size: USD 5.21 billion
- 2031 Forecast: USD 11.68 billion
- CAGR: 12.1% (2024–2031)
Growth Catalysts
· CAR-T and T-Cell Therapy Expansion: Growing demand for efficient harvesting systems.
· Biomanufacturing Growth: Crucial for antibody, vaccine, and cell therapy production.
· Automation Surge: Movement towards closed, single-use harvesting solutions.
Segment Insights
- Top product type: Automated harvesting systems hold a 55% market share.
- Key end users: Biopharma companies and CDMOs drive demand.
- Regional Leaders: North America has the largest share, followed by Europe and Asia-Pacific.
Competitive Overview (2024)
- Thermo Fisher – 21%: Comprehensive CTS™ and Dynabeads™ platforms.
- Danaher (Cytiva) – 18%: Leading in cell processing automation.
- Merck – 14%: Excelling in GMP-compliant harvesting solutions.
- Others – 47%: Combination of specialty providers and regional manufacturers.
Outlook to 2031
The next decade will witness a shift toward modular, AI-integrated, closed-system harvesting technologies, enabling decentralized manufacturing and faster clinical deployment of cell-based therapies. Emerging markets will experience significant growth due to investments in regenerative medicine infrastructure.
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian